Skip to content

A randomized controlled trial of cognitive-Behavioral therapy for schizophrenia

The research about efficacy of Cognitive-Behavioral therapy for schizophrenia

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000124
Enrollment
Unknown
Registered
2008-07-15
Start date
2008-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

The group of supportive psychotherapy combined med:From the first to 12th week, 12 sessions of supportive psychotherapy are conducted weekly
3 sessions are conducted to promote maintenance every 3 week from the 16th to 24th week, and the remaining 60 weeks is follow-up period.
The group of CBT combined medication:From the first to 12th week, 12 sessions of CBT are conducted weekly

Sponsors

Beijing Anding hospital affiliated to capital medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged between 18 and 60 years; Schizophrenia diagnosis according to DSM-IV criteria; PNASS total score greater than 60; Using stable antipsychotic medication for at least 2 weeks prior to entering the study; Received only one antipsychotic medication; Patients and one of their parents signed informed consent;The educational background higher than junior middle school (including junior middle school).

Exclusion criteria

Exclusion criteria: Other primary or co-primary psychiatric disorder; In the PNASS subscale: conceptual disorganization >=4, poor rapport >=4, lack of spontaneity and flow of conversation>=5; Undergoing MECT at the latest 1 month; Suffering from serious physical disease.

Design outcomes

Primary

MeasureTime frame
Coping Questionnaire;The Psychotic Symptom Rating Scales (PSYRATS);Personal and social performance scale (PSP);The positive and negative symptoms of schizophreni;Irrational beliefs Scale (IBS);Schizophrenic symptoms attribution questionnaire (SAQS);The Clinical Global Impressions (CGI) scal;

Secondary

MeasureTime frame
The World Health Organization Quality of Life Questionary (WHOQOL-BREF);Insight questionnair;

Countries

China

Contacts

Public ContactZhanjiang Li
lizhanjiang1221@sina.com+86 010 58303004

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026